Virtual Biopsy Market Outlook Highlighting Key Drivers And Market Evolution

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Does The Market Size Of The Virtual Biopsy Market Compare Between 2026 And 2030?

The virtual biopsy market has seen significant expansion in recent years. This market is set to expand from $0.71 billion in 2025 to $0.79 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 11.9%. The historical drivers for this growth include the reliance on traditional biopsy procedures, the existing limitations in imaging technology capabilities, the rising prevalence of chronic diseases, the expansion of hospital and diagnostic infrastructure, and the growing demand for accurate cancer diagnostics.

The virtual biopsy market is projected to experience substantial expansion over the upcoming years. By 2030, its valuation is anticipated to reach $1.23 billion, demonstrating a compound annual growth rate (CAGR) of 11.7%. This projected growth during the forecast period stems from factors such as progress in imaging algorithms and AI analytics, the broadening of diagnostic applications in oncology and neurology, greater acceptance in managing cardiovascular and ophthalmological conditions, its incorporation into personalized medicine strategies, and heightened investment in research facilities and diagnostic centers. Key trends for this period encompass a rise in the use of non-invasive diagnostic methods, a growing imperative for early disease identification, the fusion of sophisticated imaging with predictive analytics, an broadening of virtual biopsy’s utility across numerous therapeutic domains, and an increasing emphasis on patient well-being and faster recuperation.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/virtual-biopsy-global-market-report

Which Major Drivers Are Influencing The Expansion Of The Virtual Biopsy Market?

The increasing incidence of cancer-related conditions is anticipated to fuel the expansion of the virtual biopsy market in the future. Oncological disorders involve the uncontrolled proliferation and dissemination of atypical cells within the body. This surge in cancer cases is largely attributed to shifts in lifestyle, including inadequate nutrition, sedentary habits, smoking, and heightened exposure to environmental contaminants. Virtual biopsy plays a crucial role by improving the diagnosis and oversight of these disorders, offering non-invasive, immediate imaging data that lessens the necessity for conventional tissue biopsies while boosting precision and patient well-being. For example, a January 2023 report from Rock Health, a U.S.-based digital health research firm, indicated a projection of 1,958,310 new cancer cases in the U.S. for 2023, marking an increase from approximately 1.9 million new cases recorded in 2022. Consequently, the growing occurrence of oncological disorders is propelling the development of the virtual biopsy market.

What Are The Main Segments Within The Virtual Biopsy Market Segment Structure?

The virtual biopsy market covered in this report is segmented –

1) By Target Thrapeutic Areas: Oncological Disorders, Neurological Disorders, Cardiovascular Disorders, Ophthalmological Disorders, Endocrine Disorders, Gastrointestinal Disorders, Other Target Therapeutic Areas

2) By Cancer Targeted: Solid Malignancies, Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Brain Cancer, Other Cancer Targeteds

3) By Imaging Technologies: Magnetic Resonance Imaging, Computed Tomography, X-Ray, Ultrasound, Other Imaging Technologies

4) By End Users: Hospitals And Clinics, Research Institutes And Diagnostic Centers, Other End Users

Subsegments:

1) By Oncological Disorders: Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, Liver Cancer, Brain Tumors, Other Cancers

2) By Neurological Disorders: Alzheimer’s Disease, Parkinson’s Disease, Multiple Sclerosis, Epilepsy, Brain Injuries, Stroke, Other Neurological Conditions

3) By Cardiovascular Disorders: Coronary Artery Disease, Heart Failure, Arrhythmias, Aortic Aneurysm, Valvular Heart Disease, Myocardial Infarction, Other Cardiovascular Conditions

4) By Ophthalmological Disorders: Age-Related Macular Degeneration, Diabetic Retinopathy, Glaucoma, Retinal Vein Occlusion, Cataracts, Other Eye Disorders

5) By Endocrine Disorders: Diabetes Mellitus, Thyroid Disorders, Adrenal Gland Disorders, Pituitary Gland Disorders, Parathyroid Disorders, Other Endocrine Conditions

6) By Gastrointestinal Disorders: Inflammatory Bowel Disease, Colorectal Polyps, Gastric Ulcers, Liver Cirrhosis, Pancreatic Disorders, Hepatitis, Other Gastrointestinal Conditions

7) By Other Target Therapeutic Areas: Musculoskeletal Disorders, Renal Disorders, Pulmonary Disorders, Hematologic Disorders, Dermatological Disorders, Infectious Diseases, Other Miscellaneous Conditions

Which Trends Are Shaping The Virtual Biopsy Market?

Major companies operating within the virtual biopsy market are prioritizing the development of technologically advanced solutions and obtaining regulatory approvals, such as for the magnetic resonance spectroscopy (MRS) platform, with the aim of improving non-invasive diagnostic precision and delivering real-time analysis for early disease detection and customized treatment. Magnetic resonance spectroscopy (MRS) is a non-invasive imaging technique that supports virtual biopsy by providing detailed molecular information about tissues, facilitating accurate, real-time disease identification and monitoring without the need for invasive interventions. As an illustration, in November 2023, BrainSpec Inc., a US-based healthtech company, received approval from the U.S. Food and Drug Administration (FDA) for its artificial intelligence (AI)-driven BrainSpec platform. This technology leverages advanced artificial intelligence (AI) analysis of MR spectroscopy data to measure brain metabolites such as 2-hydroxyglutarate, thereby enabling non-invasive virtual biopsies for the diagnosis of conditions like gliomas, Alzheimer’s, and multiple sclerosis. The system integrates effortlessly with conventional magnetic resonance imaging (MRI) scanners, automates data processing, and generates results in minutes. It further utilizes a reference database of brain chemistry to boost diagnostic accuracy.

Who Are The Companies Participating In The Virtual Biopsy Market?

Major companies operating in the virtual biopsy market are Siemens Healthineers AG, GE Healthcare, Canon Medical Systems, Philips Healthcare, Fujifilm Healthcare, Esaote SpA, Samsung Medison, Perspectum Ltd, QUIBIM SL, ImageBiopsy Lab GmbH, Deep Bio Inc, BrainSpec Inc, Oncoustics Inc, AI Metrics LLC, Zebra Medical Vision, Arterys Inc, Aidoc Medical, Viz ai, Subtle Medical, Gleamer AI

Get The Full Virtual Biopsy Market Report:

https://www.thebusinessresearchcompany.com/report/virtual-biopsy-global-market-report

Which Region Is The Largest In The Virtual Biopsy Market?

North America was the largest region in the virtual biopsy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the virtual biopsy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Virtual Biopsy Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/virtual-biopsy-global-market-report

Browse Through More Reports Similar to the Global Virtual Biopsy Market 2026, By The Business Research Company

Virtual Clinical Trials Market Report 2026

https://www.thebusinessresearchcompany.com/report/virtual-clinical-trials-global-market-report

Biopsy Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/biopsy-devices-global-market-report

Biopsy Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/biopsy-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795